Known mutations of apoB account for only a small minority of hypobetalipoproteinemia.

Low LDL cholesterol and apoB levels in plasma cosegregate with mutations of apoB in some kindreds with familial hypobetalipoproteinemia. Approximately 35 apoB mutations, many specifying apoB truncations, have been described. Based on the centile nomenclature where the full-length nature apoB consisting of 4536 amino acids is designated as apoB-100, only those truncations of apoB >25% of normal length are detectable in plasma. Previously, we reported on five unrelated kindreds with familial hypobetalipoproteinemia in whom although no apoB truncations were detectable in plasma, low apoB levels were nevertheless linked to the apoB gene. In one of those kindreds, we reported a donor splice site mutation in intron 5 (specifying apoB- 4). We now describe a nonsense mutation in exon 10 (apoB-9) in two of the other unrelated families. Both the apoB-4 and apoB-9 mutations have been reported by others in unrelated families. Recurrent mutations of apoB-40 and apoB-55 also have been reported, suggesting that recurrent mutations of apoB may account for an appreciable proportion of familial hypobetalipoproteinemia kindreds. To test this hypothesis, we searched for four apoB mutations whose products are not detected in plasma including the apoB-4, apoB-9, and two other previously reported mutations in exons 21 and 25. We studied three groups with plasma cholesterols <130 mg/dl in whom no apoB truncations were detected in plasma: a) 28 FHBL probands from St. Louis, b) 151 individual St. Louisians, and c) 28 individual Sicilians. One subject from the 28 kindreds and two subjects among 151 hypobeta individuals from St. Louis harbored the exon 10 mutation. None of the other mutations were detected. Thus, among hypobeta lipoproteinemic subjects without any detectable apoB truncations in plasma, <5% had an apoB truncation-producing mutation. As only about 0.5% of hypobeta lipoproteinemic subjects have plasma-detectable apoB truncations, our data suggest that the known apoB truncations account for only a small proportion of hypocholesterolemia.

[1]  P. Kwok,et al.  Donor splice mutation (665 + 1 G_T) in familial hypobetalipoproteinemia with no detectable apoB truncation. , 1998, American journal of medical genetics.

[2]  Jingshi Wu,et al.  Genetic heterogeneity in familial hypobetalipoproteinemia: linkage and non-linkage to the apoB gene in Caucasian families. , 1998, American journal of medical genetics.

[3]  P. Kwok,et al.  Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55). , 1998, Atherosclerosis.

[4]  U. Francke,et al.  Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome , 1997, Nature Genetics.

[5]  D. Noto,et al.  Organ loci of catabolism of short truncations of apoB. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Ordovás,et al.  Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  C. Aguilar-Salinas,et al.  Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes. , 1996, Journal of lipid research.

[8]  P. Wilson,et al.  Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. , 1996, Clinical chemistry.

[9]  P. Wilson,et al.  Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels. , 1995, Circulation.

[10]  E. Krul,et al.  Dysbetalipoproteinemia in a kindred with hypobetalipoproteinemia due to mutations in the genes for ApoB (ApoB-70.5) and ApoE (ApoE2). , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  P. Talmud,et al.  Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. , 1994, Journal of lipid research.

[12]  E. Krul,et al.  Lengths of truncated forms of apolipoprotein B (apoB) determine their intestinal production. , 1992, Biochemical and biophysical research communications.

[13]  Carolyn A. Converse,et al.  A novel truncated apolipoprotein B (apo B55) in a patient with familial hypobetalipo‐proteinemia and atypical retinitis pigmentosa , 1992, Clinical genetics.

[14]  E. Krul,et al.  ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. , 1992, Journal of lipid research.

[15]  G. Schonfeld,et al.  Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo. , 1992, The Journal of clinical investigation.

[16]  Robert V Farese,et al.  Apolipoprotein B gene mutations affecting cholesterol levels , 1992, Journal of internal medicine.

[17]  J. Breslow,et al.  ApoB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. , 1991, Journal of lipid research.

[18]  B. Mccarthy,et al.  An expression system for human apolipoprotein B100 in a rat hepatoma cell line. , 1990, The Journal of biological chemistry.

[19]  E. Boerwinkle,et al.  Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia. , 1989, Arteriosclerosis.

[20]  S. Korman,et al.  Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination. , 1989, The Journal of biological chemistry.

[21]  S. Humphries,et al.  Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. , 1988, Nucleic acids research.

[22]  J. Scott,et al.  Regional specificities of monoclonal anti-human apolipoprotein B antibodies. , 1988, Journal of lipid research.

[23]  J. Polonovski,et al.  [Structure and metabolism of plasma lipoproteins]. , 1983, Pathologie-biologie.

[24]  C. Aguilar-Salinas,et al.  Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  E. Salido,et al.  Isolation and characterization of XE169, a novel human gene that escapes X-inactivation. , 1994, Human molecular genetics.

[26]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .